- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sitagliptin
Total 819 results
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
David D'Alessio, M.D.Merck Sharp & Dohme LLCCompleted
-
Lund UniversityCompleted
-
TakedaTerminatedDiabetes Mellitus, Type 2United States, Ukraine, Poland, Malaysia, Canada, Peru, Philippines, Hungary, Russian Federation, South Africa, Argentina, Croatia, Thailand
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Japan, Czechia, Hungary, Poland, Spain
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2
-
The University of Texas Health Science Center at...Completed
-
University of ArkansasUniversity Hospital, Geneva; Université de MontréalTerminatedHepatic Encephalopathy | Cirrhosis | Refractory Ascites | Hepatic HydrothoraxUnited States, Canada, Switzerland
-
Shahid Beheshti University of Medical SciencesRecruitingPolycystic Ovary Syndrome | Infertility | ARTIran, Islamic Republic of
-
University College DublinCompletedType 2 Diabetes Mellitus | PsoriasisIreland
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)Germany
-
GWT-TUD GmbHTerminatedDiabetes Mellitus Type 2Germany
-
Merck Sharp & Dohme LLCCompleted
-
Bio-innova Co., LtdNot yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Khoo Teck Puat HospitalCompletedType II Diabetes in Subjects BMI 27 to 32Singapore
-
Genuine Research Center, EgyptEva PharmaCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan, Korea, Republic of, South Africa, Hong Kong, Brazil, China, Ukraine
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type II
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
Boehringer IngelheimCompleted
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Amsterdam UMC, location VUmcEU FP7: SAFEGUARD consortiumCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, Mexico, Germany, Greece, Argentina, India, Australia
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Sadat City UniversityBeni-Suef UniversityCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
SanofiCompletedType 2 Diabetes MellitusBrazil, Peru, United States, Australia, Canada, Chile, Germany, Guatemala, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2United States, Puerto Rico, Germany, United Kingdom, Austria
-
St. Jude Children's Research HospitalThrasher Research FundTerminated
-
DiMango, Emily, M.D.Novartis; Genentech, Inc.Completed
-
National Center for Research Resources (NCRR)Children's National Research InstituteCompletedMuscular Dystrophy, DuchenneUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Bio-innova Co., LtdNot yet recruiting
-
The Catholic University of KoreaBayerCompletedType 2 Diabetes MellitusKorea, Republic of
-
Emory UniversityMerck Sharp & Dohme LLC; University of Michigan; Temple University; Ohio UniversityCompleted
-
Seoul National University HospitalCompletedDiabetes MellitusKorea, Republic of
-
Sheba Medical CenterCompletedDiabetes Mellitus Type 2Israel
-
Beijing Tongren HospitalCompleted